Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In August 2009, the MHRA and the Department of Health issued consultation MLX 362, which contained proposals to expand the scope of Patient Group Directions (PGDs) to enable the sale, supply and administration of certain medicines by dental therapists and dental hygienists.
The proposals aim to enable dental therapists and dental hygienists to administer local anaesthesia and to sell or supply fluoride supplements and toothpastes with high fluoride content of 2800 and 5000 parts per million (ppm).
A summary of the replies to the consultation is attached.
The relevant amendments were made and laid in Parliament in late March/early April and will come into effect on 1 June 2010. The relevant Statutory Instrument (SI 2010/ 1136) can be viewed on the Office of Public Sector Information website.
Download documents:
-
Public consultation (MLX 362): Sale, supply and administration of medicines by dental hygienists and dental therapists under a patient group direction - summary of responses (16Kb)
-
Public consultation (MLX 362): Sale, supply and administration of medicines by dental hygienists and dental therapists under a patient group direction (112Kb)
-
Public consultation (MLX 362): Sale, supply and administration of medicines by dental hygienists and dental therapists under a patient group direction: consultation list (21Kb)
